# CEO turned informant: How the FDA built a case against executives promising cheap medications

- Source: CNBC Top News
- Published: 2026-11-18T21:07:14+00:00
- Category: Markets
- Original: https://www.cnbc.com/2026/11/18/fda-canarx-case-informant.html
- Canonical: https://groundlevelnews.com/story/ceo-turned-informant-how-the-fda-built-a-case-against-executives-promi-e4c3b7/

The FDA's unprecedented criminal case against an alternative funding program hinged on the cooperation of a peer CEO, according to a court record.

_Ground Level News shows a short summary only; the full article and all rights belong to CNBC Top News._
